July/August 2017
Prescription Drug Advertising and Promotion Regulations and Enforcement in Select Global Markets
Update Magazine | July/August 2017
“Consistent Communications”: FDA’s Incremental Expansion of Promotional Bounds
Update Magazine | July/August 2017
Sales Reps in the OR: Best Practices for Medical Device Manufacturers
Update Magazine | July/August 2017
Process Labeling: The Challenges of Transparency
Update Magazine | July/August 2017
California Trial Court Cuts Plaintiffs’ Bait in Tuna Misbranding Suit
Update Magazine | July/August 2017
Case Note: Sandoz v. Amgen
Update Magazine | July/August 2017
FDA Sharpens its Focus on Regenerative Medicine Regulation
Update Magazine | July/August 2017
Spotlight on Tobacco: A Model Risk Continuum for Tobacco and Nicotine Products
Update Magazine | July/August 2017
The Butterfly Effect: Reuse of a Needle Guide Triggers “Fundamental Threat to Federal-State Balance”
Update Magazine | July/August 2017
May/June 2017
Drugs and Biologics: New Administration, New Legislation, New Precedents
Update Magazine | May/June 2017
Momentum Builds for Medical Device Cybersecurity to Level Up
Update Magazine | May/June 2017
Food and Dietary Supplement Class Actions
Update Magazine | May/June 2017
Tobacco Deeming: One Year Later
Update Magazine | May/June 2017
FDA Inspections: The Changing Landscape
Update Magazine | May/June 2017
21st Century Cures Act Implementation
Update Magazine | May/June 2017
FDLI Annual: By the Numbers
Update Magazine | May/June 2017
March/April 2017
LDTs: The Saga Continues
Update Magazine | March/April 2017
Factors to Consider Before Submitting a De Novo Request
Update Magazine | March/April 2017
Intellectual Property for the Food and Drug Law Professional: The Product Development Process
Update Magazine | March/April 2017
21st Century Cures Act Provides (Some) Clarity on FDA’s Regulation of Software
Update Magazine | March/April 2017
Interview: James Valentine Talks to Christine McSherry, Jett Foundation
Update Magazine | March/April 2017
January/February 2017
Letter from the Chair
Update Magazine | January/February 2017
4th Annual Eric M. Blumberg Memorial Lecture
Update Magazine | January/February 2017
Voluntary and Mandatory Claims About Foods and Genetic Engineering
Update Magazine | January/February 2017
FDA’s 2016 New Dietary Ingredient Draft Guidance
Update Magazine | January/February 2017
Top 10 Food and Tobacco Product Issues in Canada
Update Magazine | January/February 2017
India: Paradigm Shift in Food Regulatory Environment
Update Magazine | January/February 2017
FDLI Welcomes New Board Members and Executive Committee
Update Magazine | January/February 2017
Update EXTRA
Update EXTRA is an occasional electronic-only feature of Update magazine designed to provide interviews, reporting, and analysis on emerging issues of broad interest to our community.
FDA Looks at Improving Implementation of the Hatch-Waxman Amendments
Update EXTRA | July 27, 2017
Continuing the Discourse: FDA’s Public Hearing on Off-Label Communications
Update EXTRA | November 17, 2016
Enforcement Issue | November/December 2016
FDCA Conviction without Evidence of Knowledge or Intent?
Update Magazine | November/December 2016
A Brave New Food Enforcement World
Update Magazine | November/December 2016
New Antitrust Risks from Introducing New Drugs
Update Magazine | November/December 2016
CRN on the CRN-NAD Advertising Review Program
Update Magazine | November/December 2016
The NAD: A Force in Shaping Food and Dietary Supplement Advertising
Update Magazine | November/December 2016
Fighting with KINDness: FDA’s Unhealthy Enforcement of the “Healthy” Nutrient Content Claim Regulation
Update Magazine | November/December 2016
Interview Amy Rick Talks to Stephen Ubl, PhRMA
Update Magazine | November/December 2016
EU Agrees on New Medical Device and IVD Regulation
Update Magazine | November/December 2016
GLOBAL FOCUS: The Approval and Substitutability of Biosimilars: Potential Impact on Use and Competition
Update Magazine | November/December 2016